Drugs / Rejuvinex
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02492945 | Jun 2015 → Sep 2016 | epicondylitis | Seoul National University Bundang Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rejuvinex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02492945 ↗ |
| Route | Other | “ultrasonography-guided injection” NCT02492945 ↗ |